A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.
Hong DS; Choe JH; Naing A; Wheler JJ; Falchook GS; Piha-Paul S; Moulder SL; George GC; Choe JM; Strauss LC; Gallick GE; Kurzrock R; Investigational New Drugs, 2013, vol. 31, issue 4, p 918, ISSN 15730646. ISBN 15730646.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef